Novo Nordisk A/S (NVO) Profit Margin History

Historical gross, operating and net quarterly profit margin for Novo Nordisk A/S (NVO) over the last 10 years. The current net profit margin for Novo Nordisk A/S as of October 20, 2017 is 33.82%.

Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $128.903B $15.976B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.